These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 20474081)
1. The value of E-cadherin/beta-catenin expression in imprints of NCSLC: relationship with clinicopathological factors. Pagaki E; Patsouris E; Gonidi M; Athanassiadou AM; Maurikakis M; Athanassiades P; Chelidonis G; Athanassiadou P Diagn Cytopathol; 2010 Jun; 38(6):419-24. PubMed ID: 20474081 [TBL] [Abstract][Full Text] [Related]
2. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis]. Tang XJ; Zhou QH; Zhang SF; Liu LX Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109 [TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of vascular endothelial growth factor-A and E-cadherin expression in completely resected pathologic stage I non-small cell lung cancer. Lin Q; Li M; Shen ZY; Xiong LW; Pan XF; Gen JF; Bao GL; Sha HF; Feng JX; Ji CY; Chen M Jpn J Clin Oncol; 2010 Jul; 40(7):670-6. PubMed ID: 20382636 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical alpha- and beta-catenin and E-cadherin expression and their clinicopathological significance in human lung adenocarcinoma. Nozawa N; Hashimoto S; Nakashima Y; Matsuo Y; Koga T; Sugio K; Niho Y; Harada M; Sueishi K Pathol Res Pract; 2006; 202(9):639-50. PubMed ID: 16843618 [TBL] [Abstract][Full Text] [Related]
5. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207 [TBL] [Abstract][Full Text] [Related]
6. [Expressions of E-cadherin in non-small cell lung cancer and it correlation with prognosis]. Qiao GB; Wu YL; Ou W; Yang XN; Zhong WZ; Lin JY; Zhao J; Xie D; Guan XY Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(14):913-7. PubMed ID: 16083620 [TBL] [Abstract][Full Text] [Related]
7. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. Yoshida R; Kimura N; Harada Y; Ohuchi N Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480 [TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor and the adhesion molecule E-cadherin in non-small cell lung cancer. Stefanou D; Goussia AC; Arkoumani E; Agnantis NJ Anticancer Res; 2003; 23(6C):4715-20. PubMed ID: 14981918 [TBL] [Abstract][Full Text] [Related]
9. Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium. Kato Y; Hirano T; Yoshida K; Yashima K; Akimoto S; Tsuji K; Ohira T; Tsuboi M; Ikeda N; Ebihara Y; Kato H Lung Cancer; 2005 Jun; 48(3):323-30. PubMed ID: 15893000 [TBL] [Abstract][Full Text] [Related]
10. Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China. Chen XF; Zhang HT; Qi QY; Sun MM; Tao LY Lung Cancer; 2005 Apr; 48(1):69-76. PubMed ID: 15777972 [TBL] [Abstract][Full Text] [Related]
11. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma. Guo C; Liu QG; Yang W; Zhang ZL; Yao YM Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495 [TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma. Kim JS; Han J; Shim YM; Park J; Kim DH Cancer; 2005 Nov; 104(9):1825-33. PubMed ID: 16177988 [TBL] [Abstract][Full Text] [Related]
14. Loss of expression of E-cadherin and beta-catenin is associated with progression of pulmonary adenocarcinoma. Awaya H; Takeshima Y; Amatya VJ; Ishida H; Yamasaki M; Kohno N; Inai K Pathol Int; 2005 Jan; 55(1):14-8. PubMed ID: 15660698 [TBL] [Abstract][Full Text] [Related]
15. DNA ploidy, E-cadherin, beta-catenin expression and their clinicopathologic significance in imprints of non-small cell lung cancer. Chelidonis G; Kavantzas N; Patsouris E; Pagaki E; Athanasiadou AM; Agrogiannis G; Athanasiadou P Anal Quant Cytol Histol; 2009 Oct; 31(5):332-9. PubMed ID: 20701101 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors. Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114 [TBL] [Abstract][Full Text] [Related]
17. Expression of dysadherin and cytokeratin as prognostic indicators of disease-free survival in patients with stage I NSCLC. Ono K; Uramoto H; Hanagiri T Anticancer Res; 2010 Sep; 30(9):3273-8. PubMed ID: 20944097 [TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival. Inagawa S; Itabashi M; Adachi S; Kawamoto T; Hori M; Shimazaki J; Yoshimi F; Fukao K Clin Cancer Res; 2002 Feb; 8(2):450-6. PubMed ID: 11839663 [TBL] [Abstract][Full Text] [Related]
20. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma. Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]